Nivolumab-induced toxicity profile in patients with advanced or metastasized lung cancer treated with Viscum album L. extracts

被引:0
|
作者
Thronicke, A. [1 ]
Oei, S. L. [1 ]
Grah, C. [2 ]
Matthes, B. [2 ]
Schad, F. [2 ]
机构
[1] Forschungsinst Havelhohe gGmbH, Berlin, Germany
[2] Gemeinschaftskrankenhaus Havelhohe, Berlin, Germany
关键词
D O I
暂无
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
514
引用
收藏
页码:110 / 110
页数:1
相关论文
共 50 条
  • [31] Predictive Factors of Nivolumab-induced Hypothyroidism in Patients with Non-small Cell Lung Cancer
    Maekura, Toshiya
    Naito, Maiko
    Tahara, Masahiro
    Ikegami, Naoya
    Kimura, Yohei
    Sonobe, Shoko
    Kobayashi, Takehiko
    Tsuji, Taisuke
    Minomo, Shojiro
    Tamiya, Akihiro
    Atagi, Shinji
    IN VIVO, 2017, 31 (05): : 1035 - 1039
  • [32] A systematic review and meta-analysis on the survival of cancer patients treated with a fermented Viscum album L. extract (Iscador) - an update of findings
    Ostermann, Thomas
    Appelbaum, Sebastian
    Poier, Desiree
    Boehm, Katja
    Raak, Christa
    Buessing, Arndt
    PHYTOMEDICINE, 2019, 61
  • [33] Prolonged overall survival in patients with metastasized non-small cell lung carcinoma after combined treatment of adjuvant chemotherapy and Viscum album L. versus chemotherapy alone, a cancer registry analysis
    Matthes, B.
    Thronicke, A.
    Merkle, A.
    Grah, C.
    Matthes, H.
    Schad, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2018, 41 : 220 - 221
  • [34] Efficacy and Safety of Viscum Album (Helixor M) to Treat Malignant Pleural Effusion in Patients with Advanced Lung Cancer
    Lee, Y.
    Jung, I.
    Lee, S.
    JOURNAL OF THORACIC ONCOLOGY, 2017, 12 (11) : S2160 - S2160
  • [35] Nivolumab-induced interstitial lung disease analysis of two phase II studies patients with recurrent or advanced non-small-cell lung cancer
    Kato, Terufumi
    Masuda, Noriyuki
    Nakanishi, Yoichi
    Takahashi, Masashi
    Hida, Toyoaki
    Sakai, Hiroshi
    Atagi, Shinji
    Fujita, Shiro
    Tanaka, Hiroshi
    Takeda, Koji
    Satouchi, Miyako
    Namba, Yoshinobu
    Tamura, Tomohide
    LUNG CANCER, 2017, 104 : 111 - 118
  • [36] Comparison of RECIST and iRECIST criteria in patients with advanced lung cancer treated with nivolumab
    Singla, Rishu
    Jajodia, Ankush
    Agrawal, R. K.
    Rao, Avinash
    Pasricha, Sunil
    Batra, Ullas
    JOURNAL OF CANCER RESEARCH AND THERAPEUTICS, 2023, 19 (05) : 1212 - 1218
  • [37] P01.18. Triterpene acid containing Viscum album L. extracts mediate apoptosis in paediatric solid cancer cells
    G Kauczor
    C Delebinski
    S Jäger
    K Seeger
    G Seifert
    BMC Complementary and Alternative Medicine, 12 (Suppl 1):
  • [38] Combination of standard therapy and Viscum album L. in patients with prostate cancer, a real-world cancer registry analysis
    Thronicke, A.
    Oei, S. L.
    Matthes, H.
    Schad, F.
    ONCOLOGY RESEARCH AND TREATMENT, 2021, 44 : 300 - 300
  • [39] Impact of Oncological Therapy and Viscum Album L. Treatment on Health Related Quality of Life in Breast Cancer Patients
    Oei, Shia Li
    Thronicke, Anja
    Kroez, Matthias
    von Trott, Philipp
    Matthes, Harald
    Schad, Friedemann
    ONCOLOGY RESEARCH AND TREATMENT, 2020, 43 : 158 - 158
  • [40] The Internal Coherence of Breast Cancer Patients Is Associated with the Decision-Making for Chemotherapy and Viscum album L. Treatment
    Oei, Shiao Li
    Thronicke, Anja
    Kroez, Matthias
    Herbstreit, Cornelia
    Schad, Friedemann
    EVIDENCE-BASED COMPLEMENTARY AND ALTERNATIVE MEDICINE, 2018, 2018